CA2255652E - Isobutylgaba et ses derives utilises pour le traitement de la douleur - Google Patents

Isobutylgaba et ses derives utilises pour le traitement de la douleur

Info

Publication number
CA2255652E
CA2255652E CA2255652A CA2255652A CA2255652E CA 2255652 E CA2255652 E CA 2255652E CA 2255652 A CA2255652 A CA 2255652A CA 2255652 A CA2255652 A CA 2255652A CA 2255652 E CA2255652 E CA 2255652E
Authority
CA
Canada
Prior art keywords
pain
compound according
treated
paw
isobutylgaba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2255652A
Other languages
English (en)
Other versions
CA2255652A1 (fr
CA2255652C (fr
Inventor
Lakhbir Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Priority claimed from PCT/US1997/012390 external-priority patent/WO1998003167A1/fr
Publication of CA2255652A1 publication Critical patent/CA2255652A1/fr
Application granted granted Critical
Publication of CA2255652C publication Critical patent/CA2255652C/fr
Publication of CA2255652E publication Critical patent/CA2255652E/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

La présente invention concerne un procédé d'utilisation de certains analogues de l'acide glutamique et de l'acide gamma -aminobutyrique dans le traitement de la douleur.
CA2255652A 1996-07-24 1997-07-16 Isobutylgaba et ses derives utilises pour le traitement de la douleur Expired - Lifetime CA2255652E (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2233796P 1996-07-24 1996-07-24
US60/022,337 1996-07-24
PCT/US1997/012390 WO1998003167A1 (fr) 1996-07-24 1997-07-16 Isobutylgaba et ses derives utilises pour le traitement de la douleur

Publications (3)

Publication Number Publication Date
CA2255652A1 CA2255652A1 (fr) 1998-01-29
CA2255652C CA2255652C (fr) 2004-07-13
CA2255652E true CA2255652E (fr) 2004-07-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP0934061B1 (fr) Isobutylgaba et ses derives utilises pour le traitement de la douleur
CA2430470C (fr) Nouvelle utilisation d'une classe de composes peptidiques pour traiter l'allodynie ou d'autres types de douleurs chroniques ou illusionnelles differentes
AU2002257680A1 (en) Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
JP2018021023A (ja) （ｓ）２−ｎ（３−ｏ−（プロパン２−オール）−１−プロピル−４−ヒドロキシベンゼン）−３−フェニルプロピルアミドの単離された立体異性体型
EP3818981A1 (fr) Combinaison pharmaceutique synergique de l'énantiomère actif s-kétorolac et de gabapentine pour le traitement de la douleur neuropathique
CA2255652E (fr) Isobutylgaba et ses derives utilises pour le traitement de la douleur
US20080139651A1 (en) Compounds useful for treating neurological disorders
HK1021134B (en) Isobutylgaba and its derivatives for the treatment of pain
HK1143088A (en) Novel use of a peptide class of compounds for treating diabetic neuropathic pain